logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2011 or most recent year available

Part (viii) All cocaine (HCI and ‘crack’) inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium13.57.924.054.62297
Bulgaria50.0:50.0:20
Czech Republic35.714.342.97.1142
Denmark:44.433.322.292
Germany::::::
Estonia::::::
Ireland160.05.723.810.510521
Greece28.231.019.721.1713
Spain::::::
France8.26.717.967.213410
Italy::::::
Cyprus40.015.010.035.0200
Latvia::::::
Lithuania::::::
Luxembourg4.24.28.383.3241
Hungary:::100.030
Malta::::::
Netherlands197.322.451.3343148
Austria56.76.718.318.3607
Poland2::::::
Portugal::::::
Romania25.033.316.725.0124
Slovenia::::::
Slovakia66.733.3::33
Finland::::00
Sweden135.44.235.425.0480
United Kingdom3::::::
Croatia:::::6
Turkey6.517.410.965.2460
Norway5033.3:16.760
Total23.79.821.644.91123214
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013